Skip to content

Alzheimer's Family Caregiver Intervention in Vietnam

Single Arm Study of Modified REACH-VA Alzheimer's Caregiver Intervention in Vietnam

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03100617
Enrollment
6
Registered
2017-04-04
Start date
2017-08-26
Completion date
2018-06-18
Last updated
2020-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia Alzheimers

Keywords

Family caregiver

Brief summary

This is a single arm pilot study of 6-8 families to test the feasibility and acceptability of a Alzheimer's family caregiver intervention in Vietnam.

Detailed description

This is a single arm pilot study of 6-8 families to test the feasibility and acceptability of a modified version of the REACH-VA caregiver intervention in Vietnam. The REACH-VA caregiver intervention is an evidence-based intervention that has been shown to be effective in multicultural populations in the US. The model has been modified for use in Vietnam. This study will test the modified model in Vietnam. Participants in this study will be adult family caregivers of non-institutionalized persons with dementia who are living in Hanoi, Vietnam. They will receive 4-6 sessions delivered over the course of 2-3 months that will included the following components: 1) education about the nature of the disease, 2) risk assessment, 3) enhancing caregiver skills and problem-solving, and 4) caregiver stress reduction. The intervention will be delivered by a social worker or nurse using a Vietnamese language versions of the REACH-VA protocol and caregiver intervention notebook.

Interventions

BEHAVIORALPsychosocial caregiver intervention

Modified version of the REACH-VA intervention for family caregivers of persons with dementia. The intervention has several components including 1) caregiver education, 2) risk assessment, 3) caregiver needs assessment, 4) caregiver skill building and problem solving, and 4) caregiver stress reduction.

Sponsors

University of South Carolina
CollaboratorOTHER
University of California, Davis
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Primary adult family caregiver of person with dementia

Exclusion criteria

* Caregivers of persons with dementia who are institutionalized

Design outcomes

Primary

MeasureTime frameDescription
Caregiver BurdenChange from baseline Zarit burden scale score to 3 months.Zarit Burden scale

Countries

Vietnam

Participant flow

Participants by arm

ArmCount
REACH-VA Family Caregiver Intervention
Behavioral intervention with several components including 1) caregiver education, 2) risk assessment, 3) caregiver needs assessment, 4) caregiver skill building and problem solving, and 4) caregiver stress reduction. Psychosocial caregiver intervention: Modified version of the REACH-VA intervention for family caregivers of persons with dementia. The intervention has several components including 1) caregiver education, 2) risk assessment, 3) caregiver needs assessment, 4) caregiver skill building and problem solving, and 4) caregiver stress reduction.
6
Total6

Baseline characteristics

CharacteristicREACH-VA Family Caregiver Intervention
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
1 Participants
Age, Categorical
Between 18 and 65 years
5 Participants
Age, Continuous51.7 years
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Vietnam
6 participants
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
1 Participants
Zarit Burden Scale 4-item7.8 units on a scale

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 6
other
Total, other adverse events
0 / 6
serious
Total, serious adverse events
0 / 6

Outcome results

Primary

Caregiver Burden

Zarit Burden scale

Time frame: Change from baseline Zarit burden scale score to 3 months.

Population: This was a feasibility study. Outcome data not collected.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026